Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer.
about
NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinonesSublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells.A three step network based approach (TSNBA) to finding disease molecular signature and key regulators: a case study of IL-1 and TNF-alpha stimulated inflammation.17-AAG suppresses growth and invasion of lung adenocarcinoma cells via regulation of the LATS1/YAP pathway.Combination therapy with HSP90 inhibitor 17-DMAG reconditions the tumor microenvironment to improve recruitment of therapeutic T cells.Exposure to ionizing radiation induced persistent gene expression changes in mouse mammary glandFluorescent ligand for human progesterone receptor imaging in live cells.Targeting HSF1 sensitizes cancer cells to HSP90 inhibition.Could the Anti-Chaperone VER155008 Replace Temozolomide for Glioma TreatmentMitochondrial unfolded protein response controls matrix pre-RNA processing and translationPhenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma.Therapeutic potency of heat-shock protein-90 pharmacological inhibitors in the treatment of gastrointestinal cancer, current status and perspectives.
P2860
Q26823209-CF6A2180-5E13-4493-A45B-FDBE41CB35F4Q33757073-ED08E207-130D-4C50-87C7-D97113A86F13Q35152688-D8B08AFC-8CAD-41A3-9AAF-215A3AC7C5F7Q35206531-43D3CA25-215D-4B52-BFD7-844CB8285A8CQ36074307-CCB89E0E-0C95-4E6A-9AB0-13EFC149FDCBQ36552489-0CDBE04C-46D8-426C-85CB-F7948070295BQ36857601-EF95EB40-3B2B-45E6-AD55-DEF4D4CA55A7Q39161041-87328D4B-CF0D-44A5-9E86-710EEB88E707Q40725479-DE2AAD46-8D2F-466D-A002-FB7382515F73Q42426838-D060B55A-28CF-486B-8B87-85417B23B7ECQ47121474-AA4A3709-AB80-4E04-927D-D711EF78C643Q47694405-6D75DC5C-7453-48A2-A893-F78B3B53CE19
P2860
Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Molecular signature of respons ...... itor, 17AAG, in breast cancer.
@ast
Molecular signature of respons ...... itor, 17AAG, in breast cancer.
@en
type
label
Molecular signature of respons ...... itor, 17AAG, in breast cancer.
@ast
Molecular signature of respons ...... itor, 17AAG, in breast cancer.
@en
prefLabel
Molecular signature of respons ...... itor, 17AAG, in breast cancer.
@ast
Molecular signature of respons ...... itor, 17AAG, in breast cancer.
@en
P2860
P356
P1433
P1476
Molecular signature of respons ...... itor, 17AAG, in breast cancer.
@en
P2093
Gonzalo Gomez
Magdalena Zajac
P2860
P2888
P356
10.1186/1755-8794-3-44
P577
2010-10-04T00:00:00Z
P5875
P6179
1015502348